Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4733338

CNC1CCC(NCc2cc(-c3ccc(C#N)cc3)ccc2F)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GPR6 P46095 3/20 0.40
KDM1A O60341 7/20 0.39
FFAR1 O14842 1/20 0.38
KIF11 P52732 1/20 0.37
MCHR1 Q99705 1/20 0.36
EGLN2 Q96KS0 1/20 0.36
HSD11B1 P28845 2/20 0.36
ADRB3 P13945 1/20 0.35
CHEK1 O14757 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4731371 0.91 MCHR1 (0.41) GPR6MCHR1
Trifluoroacetic Acid SCHEMBL4728849 0.89 MEN1 (0.42) GPR6
Trifluoroacetic Acid SCHEMBL4733331 0.89 EPHX2 (0.41) GPR6FFAR1MCHR1EGLN2
Trifluoroacetic Acid SCHEMBL4731677 0.88 PARP1 (0.36) GPR6ADRB3
Trifluoroacetic Acid SCHEMBL4730294 0.88 MCHR1 (0.39) GPR6MCHR1ADRB3
Trifluoroacetic Acid SCHEMBL4731470 0.87 TRPA1 (0.42) KIF11MCHR1ADRB3
Trifluoroacetic Acid SCHEMBL4734028 0.86 KIF11 (0.42) GPR6KIF11MCHR1
Trifluoroacetic Acid SCHEMBL4735931 0.86 HDAC1 (0.37) GPR6MCHR1
Trifluoroacetic Acid SCHEMBL4734148 0.85 FFAR1 (0.35) FFAR1MCHR1
Trifluoroacetic Acid SCHEMBL4735936 0.85 CNR1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120245184-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION ADERANS RESEARCH INSTITUTE, INC. 2012-09-27 US disclosed
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO GPR6 655/4885KDM1A 298/4885FFAR1 2703/4885
US-20120245184-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION GLI1, SHH, SMO GPR6 655/4885KDM1A 298/4885FFAR1 2703/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO GPR6 655/4885KDM1A 298/4885FFAR1 2703/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO GPR6 276/4885KDM1A 124/4885FFAR1 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.